Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masato Mochiki is active.

Publication


Featured researches published by Masato Mochiki.


Cancer | 2002

Results of Multimodality Therapy for Squamous Cell Carcinoma of Maxillary Sinus

Ken-ichi Nibu; Masashi Sugasawa; Masao Asai; Keiichi Ichimura; Masato Mochiki; Atsuro Terahara; Nobutaka Kawahara; Hirotaka Asato

A wide variety of modalities, including surgery, radiation therapy, and chemotherapy, alone or in combination, have been used for the treatment of squamous cell carcinoma (SCC) of the maxillary sinus to obtain better local control and maintain functions. However, there is still much controversy with regard to the optimum treatment.


Otolaryngology-Head and Neck Surgery | 2006

Analysis of Prognostic Factors of Nasopharyngeal Carcinoma: Impact of in Situ Hybridization for Epstein-Barr Virus Encoded Small RNA 1

Kazunari Nakao; Masato Mochiki; Ken-ichi Nibu; Masashi Sugasawa; Hiroshi Uozaki

OBJECTIVES: To evaluate the impact of clinical, histopathological, and molecular biological parameters on the prognosis of nasopharyngeal carcinoma (NPC). STUDY DESIGN AND SETTING: The clinical records of 48 patients with a diagnosis of NPC were retrospectively reviewed. In situ hybridization for Epstein-Barr virus encoded small RNA 1 (EBER-ISH) was applied for 30 paraffin-embedded specimens available. Prognostic factors of NPC were meticulously analyzed. RESULTS: The EBER-ISH signal was shown to be highly significant as a favorable prognostic factor (P = 0.007). Although EBV was more commonly associated with Type III NPC, EBER-ISH-positive Type I-II NPC had also significantly better survival rate than EBER-ISH-negative Type I-II NPC (P = 0.036). CONCLUSIONS: In addition to the WHO histopathological grade, the 1997 UICC staging, nodal status, and distant metastasis at presentation, the EBER-ISH signal was shown to be significant as a prognostic factor. SIGNIFICANCE: This is the first report to describe the EBER-ISH as an independent prognostic factor of NPC regardless of histopathology.


Acta Oto-laryngologica | 2007

Prognostic factors for hypopharyngeal cancer: a univariate and multivariate study of 142 cases

Masato Mochiki; Masashi Sugasawa; Ken-ichi Nibu; Masao Asai; Kazunari Nakao; Takahiro Asakage

Conclusions. Reduction of distant metastases is essential for better survival. Effective adjuvant chemotherapy should be developed for patients with advanced primary disease (T>2) as well as for patients with advanced nodal status (N>0 or PLN>2). Objectives. The aim of this study was to identify prognostic factors for hypopharyngeal cancer. Patients and methods. In all, 142 previously untreated patients were analyzed retrospectively; 75% of the cases were stage III or IV. Surgical resection was administered as primary treatment to 116 of the patients (82%), while 26 patients (18%) underwent primary radiotherapy. Results. The cause-specific 5-year actuarial survival was 46.3%. Distant metastases were the most frequent (23%) cause of failure, followed by local recurrence (15%), and regional recurrence (13%). Coxs regression analysis showed that the significant factors affecting cause-specific survival were N classification, T classification, number of pathological lymph node metastases (PLN), lymphatic invasion, and positive surgical margin. Similarly, T classification and PLN affected distant metastases.


Auris Nasus Larynx | 2003

Fibromatosis of the infratemporal fossa extending to the parapharyngeal space accompanied by trismus.

Yasuhiro Chihara; Masato Mochiki; Masashi Sugasawa; Ken-ichi Nibu

Fibromatosis is a tumor of fibroblastic origin that may arise in any musculoaponeurotic structure. Although fibromatosis is histologically benign, it has a tendency to invade surrounding tissues and often recur locally after treatment. A 34-year-old female patient was presented with pain in the left buccal region, left loss of visual acuity, and trismus. Computed tomographic scans revealed a large mass in the infratemporal fossa and parapharyngeal space. An open biopsy was performed and the pathological diagnosis was a fibromatosis. Surgical treatment for her trismus was performed simultaneously.


Auris Nasus Larynx | 2004

Malignant melanoma of nasal cavity: report of 16 Japanese patients.

Muneo Nakaya; Masato Mochiki; Satoshi Takeuchi; Tadashi Yuge; Kazunari Nakao; Naoki Nakamura; Masashi Sugasawa


Archives of Otolaryngology-head & Neck Surgery | 2002

Partial laryngectomy to treat early glottic cancer after failure of radiation therapy.

Makiko Toma; Ken-ichi Nibu; Kazunari Nakao; Masaki Matsuzaki; Masato Mochiki; Tadashi Yuge; Atsuro Terahara; Masashi Sugasawa


Archives of Otolaryngology-head & Neck Surgery | 2003

Detection of Epstein-Barr Virus in Metastatic Lymph Nodes of Patients With Nasopharyngeal Carcinoma and a Primary Unknown Carcinoma

Kazunari Nakao; Tadashi Yuge; Masato Mochiki; Ken-ichi Nibu; Masashi Sugasawa


Toukeibu Gan | 2004

PARTIAL PHARYNGECTOMY FOR HYPOPHARYNGEAL CARCINOMA

Takahiro Asakage; Kazunari Nakao; Masashi Sugasawa; Masato Mochiki


Japanese jornal of Head and Neck Cancer | 2003

CARCINOMA OF THE HYPOPHARYNX-ANALYSIS OF PROGNOSTIC FACTORS FOR SURVIVAL

Masato Mochiki; Masashi Sugasawa; Kazunari Nakao; Tadashi Yuge; Takashi Sakamoto; Mizuo Andou


International Conference on Head and Neck Cancer | 2002

Results of multimodality therapy for squamous cell carcinoma of maxillary sinus

Ken-ichi Nibu; Masashi Sugasawa; Masao Asai; Keiichi Ichimura; Masato Mochiki; Atsuro Terahara; Nobutaka Kawahara; Hirotaka Asato

Collaboration


Dive into the Masato Mochiki's collaboration.

Top Co-Authors

Avatar

Masashi Sugasawa

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge